TRV
Third Rock Ventures Portfolio holdings
AUM
$1.07B
This Quarter Return
+30.48%
1 Year Return
+201.55%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$961M
AUM Growth
+$961M
(+2.5%)
Cap. Flow
-$149M
Cap. Flow
% of AUM
-15.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$196M |
Top Sells
| 1 |
FMI
Foundation Medicine, Inc.
FMI
|
$237M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$73M |
| 3 |
Larimar Therapeutics
LRMR
|
$34.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
1
DELISTED
Sage Therapeutics
SAGE
| $640M | 66.66% | 8,773,073 -1,000,000 | -10% | -$73M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $196M | 20.38% | +7,393,059 | New | +$196M |
|
|
3
Larimar Therapeutics
LRMR
$310M
| $111M | 11.54% | 3,202,045 -1,000,000 | -24% | -$34.6M |
|
4
Carisma Therapeutics
CARM
$8.98M
| $13.7M | 1.42% | 4,841,591 | – | – |
|
|
FMI
5
DELISTED
Foundation Medicine, Inc.
FMI
| – | – | -4,927,234 | Closed | -$237M |
|